
FDA’s New Medical Robotics Discussion Paper: Why Cybersecurity Must Be Evaluated End to End.
FDA’s new discussion paper on medical robotics carries one message cybersecurity teams should not miss: risk cannot be assessed one component at a time. On
" " indicates required fields

FDA’s new discussion paper on medical robotics carries one message cybersecurity teams should not miss: risk cannot be assessed one component at a time. On

What Changes When Your Devices Are Already in the Field By Ken Zalevsky, VP and GM, C2A Security A revision would likely do more than

C2A Security · July 2026 · 10 min read Executive Summary Cybersecurity is no longer measured solely by an organization’s ability to prevent vulnerabilities. Increasingly, regulators, customers, and

CVE-2026-20045 does not directly affect most devices and products, but its potential impact depends entirely on how affected systems connect to them. CISA added CVE-2026-20045

Medical device manufacturers are no longer struggling to find vulnerabilities. They are struggling to decide which ones matter. As SBOM adoption has expanded, security and